Skip to main content

Stephen Gomperts, MD, PhD

Assistant Professor at Massachusetts General Hospital

Location: Boston, MA United States

Dr. Stephen Gomperts is a member of the Clinical Core of the Massachusetts Alzheimer’s Disease Research Center (MADRC) and the director of the Lewy Body Dementia Unit at Massachusetts General Hospital. His translational and clinical research focuses on molecular imaging of and therapeutics for pathological processes that contribute to Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). He is principal investigator a study to image histone deacetylase in PD using a radiolabeled inhibitor as well as on grants evaluating longitudinal PET imaging of brain amyloid and tau in PD, PD dementia and DLB. He is a co-investigator on a funded study evaluating a promising small molecule therapeutic in PD models.

Associated Grants

  • (Supplement) PET Imaging Probe Development for Alpha-synuclein


  • Assessing the Potential of Low-Dose Carbon Monoxide Therapy in Parkinson’s Disease


  • PET Imaging Probe Development for Alpha-synuclein


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.